In Australia , the 750mcg teriparatide solution is now available through specialty pharmacies , typically subject to restricted distribution . Market uptake of this stronger formulation has been comparatively constrained due to the cost , stringent patient selection , and the persistent need for counselling regarding its use and potential adverse r